Analystreport

Outlook Therapeutics, Inc. (NASDAQ: OTLK) was downgraded by analysts at Chardan Capital from a "buy" rating to a "neutral" rating.

Outlook Therapeutics, Inc.  (OTLK) 
Last outlook therapeutics, inc. earnings: 2/14 08:00 am Check Earnings Report